Evidence map›Paper›PMID 40787010›Full record

ArticleFrontiers in pediatrics2025

Case Report: A Chinese family with MYH9-RD caused by

Xiaoqiang Lian, Haixia Li, Jihong Hao, Haixin Li, Ling Xu, Shuxia Zhang, Li Cao, Ruimin Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoqiang LianDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.
Haixia LiDepartment of Anesthesiology, Handan Central Hospital, Handan, China.
Jihong HaoDepartment of Clinical Laboratory, Second Hospital of Hebei Medical University, Shijiazhuang, China.
Haixin LiDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.
Ling XuDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.
Shuxia ZhangDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.
Li CaoDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.
Ruimin LiDepartment of Clinical Laboratory, Handan Central Hospital, Handan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: MYH9-related disease (MYH9-RD) is a rare autosomal dominant genetic syndrome characterized by congenital thrombocytopenia, with a risk of developing progressive nephropathy, sensorineural deafness, and presenile cataract. Due to its presentation of isolated thrombocytopenia, it is frequently misdiagnosed as immune thrombocytopenic purpura (ITP). Methods: A 10-year-old girl with an initial diagnosis of ITP was evaluated, based on isolated thrombocytopenia and intermittent epistaxis. Clinical assessments included peripheral blood and bone marrow smear examinations to observe cellular morphology. Family history was collected to identify potential hereditary associations. Genetic testing was performed to detect potential pathogenic mutations. Results: Peripheral blood and bone marrow smears revealed giant platelets, along with blue inclusions in neutrophils, eosinophils, and monocytes-key cytological features of MYH9-RD. Family history investigation showed thrombocytopenia in the patient's mother and maternal grandmother; additionally, the mother had mild hearing impairment, and the maternal grandmother had died of renal failure. Genetic testing confirmed the presence of the MYH9 p.E1841K mutation in the patient, which was inherited from her mother. Based on these findings, the diagnosis was revised from ITP to MYH9-RD. Discussion: This case emphasizes that MYH9-RD should be considered in the differential diagnosis of unexplained thrombocytopenia, particularly when accompanied by characteristic cytological findings (e.g., giant platelets, blue inclusions in leukocytes) and a positive family history of related manifestations. The consistency of phenotypes within the affected family supports the importance of genetic screening and long-term follow-up for relatives of confirmed cases to enable early detection and management of potential complications.

Indexed as

giant plateletsinherited thrombocytopenialeukocyte inclusionMYH9 related diseasenon-muscle myosin heavy chain II-A

Identifiers

PMID40787010
PMCPMC12331753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.